GLP-1 coverage in North Dakota

Medicaid coverage of GLP-1s for obesity is optional for states under a long-standing statutory exception. North Dakota has exercised that discretion in a specific way.

North Dakota Medicaid covers weight-loss drugs but not GLP-1s.

North Dakota is listed by KFF among states covering at least one weight-loss drug while covering no GLP-1. The Midwest also carries the highest regional obesity prevalence in the country, which makes the gap more consequential here than the raw numbers suggest. Everything below is sourced — we are not going to tell you what a North Dakota clinic charges, because every provider we track is 50-state telehealth and prices the same wherever you live. What actually differs by state is coverage, and that is what this page is about.

Why North Dakota is different

North Dakota sits in the Midwest, which carries the highest regional adult obesity prevalence in the country at 35.9% — higher than the South. It covers a weight-loss drug while covering no GLP-1, which puts the strictest version of that gap in the region where prevalence is worst.

Medicaid and GLP-1s in North Dakota

Coverage for obesity is optional for states — the national picture is on our coverage index. Here is where North Dakota sits.

If you are on Medicaid in North Dakota

What to do in North Dakota: Given the regional prevalence, check the mandatory indications carefully before accepting a denial framed around weight loss.

Coverage for type 2 diabetes, cardiovascular disease and sleep apnea is mandatory everywhere, so a refusal framed around weight loss is not the end of it — and on Medicare, the $50 programme starts 1 July 2026 regardless of which state you are in.